Two Sigma Securities, LLC Organon & Co. Call Options Transaction History

Two Sigma Securities, LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$17.45 - $21.96 $64,565 - $81,252	3,700 Added 29.84%	16,100 $333,000
Q1 2024 May 15, 2024	SELL	$13.78 - $18.8 $119,886 - $163,560	-8,700 Reduced 41.23%	12,400 $233,000
Q4 2023 Feb 14, 2024	BUY	$10.95 - $17.32 $31,754 - $50,228	2,900 Added 15.93%	21,100 $304,000
Q3 2023 Nov 14, 2023	BUY	$16.59 - $23.77 $39,816 - $57,048	2,400 Added 15.19%	18,200 $315,000
Q2 2023 Aug 14, 2023	BUY	$19.27 - $24.63 $304,466 - $389,154	15,800 New	15,800 $328,000
Q3 2022 Nov 14, 2022	BUY	$23.4 - $34.25 $358,020 - $524,025	15,300 New	15,300 $358,000

793

192M

1.71M

865K

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.75B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.